Conditions Treated
Explore prescription medication options, including semaglutide, tirzepatide, sermorelin, and NAD+.
Rx required. Medications are prescribed only when appropriate.
GLP-1, peptide, and coenzyme medications
GLP-1
GLP-1 medication for weight management support
Semaglutide belongs to a class of medications known as GLP-1 receptor agonists. This medication is commonly used with medical weight loss programs and may reduce appetite and curb cravings.
GIP / GLP-1
Dual GIP/GLP-1 medication for weight management support
Tirzepatide acts on both GIP and GLP-1 receptors. This medication is commonly used with medical weight loss programs and may reduce appetite and curb cravings.
Peptide
Peptide medication for wellness and vitality support
Sermorelin is a peptide option related to growth hormone-releasing hormone pathways. It is not a GLP-1 medication. When clinically appropriate, it may improve sleep, promote recovery, and improve body composition.
Coenzyme
NAD+ medication for energy and wellness support.
NAD+ is a coenzyme involved in cellular energy production. When clinically appropriate, it may support energy recovery and overall wellness.
Compare
| Medication | Category | Primary Focus | Potential Benefits |
|---|---|---|---|
| Semaglutide | GLP-1 | Weight management | May reduce appetite and curb cravings as part of a medical weight loss program |
| Tirzepatide | GIP/GLP-1 | Weight management | May reduce appetite and curb cravings as part of a medical weight loss program |
| Sermorelin | Peptide / GHRH analog | Wellness & vitality | May improve sleep, promote recovery, and improve body composition |
| NAD+ | Coenzyme | Energy and vitality | May support energy recovery and overall wellness. |
Mechanism
Semaglutide belongs to a class of medications known as GLP-1 receptor agonists. This medication is commonly used with medical weight loss programs and may reduce appetite and curb cravings.
Tirzepatide acts on both GIP and GLP-1 receptors. This medication is commonly used with medical weight loss programs and may reduce appetite and curb cravings.
Sermorelin is a peptide option related to growth hormone-releasing hormone pathways. It is not a GLP-1 medication. When clinically appropriate, it may improve sleep, promote recovery, and improve body composition.
NAD+ is a coenzyme involved in cellular energy production. When clinically appropriate, it may support energy recovery and overall wellness.
Next Step
Start with a PeachScripts visit. A licensed provider will review your information and determine what may be appropriate.
FAQ
Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on both GIP and GLP-1 receptors. Both are commonly associated with medical weight-management treatment, but they are different medications.
No. Sermorelin is not a GLP-1 medication. It is a peptide related to growth hormone-releasing hormone pathways.
Semaglutide, tirzepatide, sermorelin, and NAD+ are commonly offered as injectable medications.
You can share which medication options you are interested in. Final prescribing decisions depend on clinical appropriateness after a licensed provider reviews your information.
No. Compounded medications are not FDA-approved. FDA does not verify compounded drugs for safety, effectiveness, or quality before they are marketed.
Prescription required. Medication availability may vary. Compounded medications, when prescribed, are not FDA-approved. FDA has reported concerns involving compounded semaglutide and tirzepatide, including dosing errors and adverse event reports, so dosing should always follow prescription instructions.
Start with a $49 visit. A licensed provider will review your information and determine what may be appropriate.